1. Home
  2. ACCO vs ABEO Comparison

ACCO vs ABEO Comparison

Compare ACCO & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCO
  • ABEO
  • Stock Information
  • Founded
  • ACCO 1893
  • ABEO 1974
  • Country
  • ACCO United States
  • ABEO United States
  • Employees
  • ACCO N/A
  • ABEO N/A
  • Industry
  • ACCO Publishing
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACCO Consumer Discretionary
  • ABEO Health Care
  • Exchange
  • ACCO Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • ACCO 353.3M
  • ABEO 332.0M
  • IPO Year
  • ACCO N/A
  • ABEO 1980
  • Fundamental
  • Price
  • ACCO $4.00
  • ABEO $6.83
  • Analyst Decision
  • ACCO Buy
  • ABEO Strong Buy
  • Analyst Count
  • ACCO 1
  • ABEO 6
  • Target Price
  • ACCO $6.00
  • ABEO $18.17
  • AVG Volume (30 Days)
  • ACCO 530.2K
  • ABEO 702.3K
  • Earning Date
  • ACCO 07-31-2025
  • ABEO 08-14-2025
  • Dividend Yield
  • ACCO 7.46%
  • ABEO N/A
  • EPS Growth
  • ACCO N/A
  • ABEO N/A
  • EPS
  • ACCO 0.49
  • ABEO 0.99
  • Revenue
  • ACCO $1,581,200,000.00
  • ABEO $400,000.00
  • Revenue This Year
  • ACCO N/A
  • ABEO N/A
  • Revenue Next Year
  • ACCO $2.11
  • ABEO $339.63
  • P/E Ratio
  • ACCO $8.21
  • ABEO $6.91
  • Revenue Growth
  • ACCO N/A
  • ABEO N/A
  • 52 Week Low
  • ACCO $3.32
  • ABEO $3.93
  • 52 Week High
  • ACCO $6.44
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • ACCO 59.22
  • ABEO 52.71
  • Support Level
  • ACCO $3.90
  • ABEO $6.70
  • Resistance Level
  • ACCO $4.01
  • ABEO $7.15
  • Average True Range (ATR)
  • ACCO 0.10
  • ABEO 0.31
  • MACD
  • ACCO 0.01
  • ABEO -0.02
  • Stochastic Oscillator
  • ACCO 79.91
  • ABEO 46.62

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: